PH27594A - Medicaments for the treatment of asthma and other respiratory disorders - Google Patents
Medicaments for the treatment of asthma and other respiratory disordersInfo
- Publication number
- PH27594A PH27594A PH41153A PH41153A PH27594A PH 27594 A PH27594 A PH 27594A PH 41153 A PH41153 A PH 41153A PH 41153 A PH41153 A PH 41153A PH 27594 A PH27594 A PH 27594A
- Authority
- PH
- Philippines
- Prior art keywords
- treatment
- respiratory disorders
- medicaments
- asthma
- salmeterol
- Prior art date
Links
- 208000023504 respiratory system disease Diseases 0.000 title abstract 2
- 208000006673 asthma Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 abstract 1
- 229960000289 fluticasone propionate Drugs 0.000 abstract 1
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960004017 salmeterol Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898920392A GB8920392D0 (en) | 1989-09-08 | 1989-09-08 | Medicaments |
| GB898923644A GB8923644D0 (en) | 1989-10-20 | 1989-10-20 | Medicaments |
| SG166294A SG166294G (en) | 1989-09-08 | 1994-11-18 | Inhalation medicaments for treating respiratory disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH27594A true PH27594A (en) | 1993-08-31 |
Family
ID=27264677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH41153A PH27594A (en) | 1989-09-08 | 1990-09-07 | Medicaments for the treatment of asthma and other respiratory disorders |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0416951B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP3042867B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE99941T1 (cg-RX-API-DMAC7.html) |
| BE (1) | BE1003053A3 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2024916C (cg-RX-API-DMAC7.html) |
| CH (1) | CH680983C9 (cg-RX-API-DMAC7.html) |
| DE (2) | DE19975040I2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0416951T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2062392T3 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2651677B1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK18695A (cg-RX-API-DMAC7.html) |
| HU (1) | HU211272A9 (cg-RX-API-DMAC7.html) |
| IE (1) | IE65535B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL95590A (cg-RX-API-DMAC7.html) |
| IT (1) | IT1241996B (cg-RX-API-DMAC7.html) |
| LU (1) | LU90392I2 (cg-RX-API-DMAC7.html) |
| NL (1) | NL990012I2 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ235221A (cg-RX-API-DMAC7.html) |
| PH (1) | PH27594A (cg-RX-API-DMAC7.html) |
| SG (1) | SG166294G (cg-RX-API-DMAC7.html) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5270305A (en) | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
| IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant |
| HU227519B1 (en) * | 1991-12-18 | 2011-07-28 | Astra Ab | Synergic pharmaceutical composition containing combination of formoterol and budesonide |
| SE9703407D0 (sv) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
| SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
| NZ511527A (en) | 1998-11-13 | 2002-10-25 | Jago Res A | Dry powder for inhalation |
| GB9903759D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
| GB9904919D0 (en) | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
| GB2354007B (en) | 1999-09-11 | 2003-10-22 | Glaxo Group Ltd | Pharmaceutical formulation of fluticasone propionate |
| JP2003518484A (ja) * | 1999-12-24 | 2003-06-10 | グラクソ グループ リミテッド | サルメテロールおよびプロピオン酸フルチカゾンの医薬用エアゾル製剤 |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| CZ2003353A3 (cs) * | 2000-08-05 | 2003-05-14 | Glaxo Group Limited | Estery steroidních thiokyselin |
| US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| FI20002215A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
| FI20002216A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit astman hoitoon |
| GB0103630D0 (en) | 2001-02-14 | 2001-03-28 | Glaxo Group Ltd | Chemical compounds |
| DE60220887T2 (de) | 2001-03-08 | 2008-02-28 | Glaxo Group Ltd., Greenford | Agonisten von beta-adrenorezeptoren |
| ATE381537T1 (de) | 2001-03-22 | 2008-01-15 | Glaxo Group Ltd | Formanilid-derivative als beta2-adrenorezeptor- agonisten |
| UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
| ES2314052T3 (es) | 2001-04-30 | 2009-03-16 | Glaxo Group Limited | Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa. |
| MXPA04002405A (es) | 2001-09-14 | 2004-05-31 | Glaxo Group Limetd | Derivados de fenetanolamina para tratamiento de enfermedades respiratorias. |
| DE10202940A1 (de) | 2002-01-24 | 2003-07-31 | Sofotec Gmbh & Co Kg | Patrone für einen Pulverinhalator |
| US7258118B2 (en) | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
| EP1757281A3 (en) * | 2002-02-04 | 2009-07-15 | Glaxo Group Limited | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| AU2003205855A1 (en) † | 2002-02-04 | 2003-09-02 | Glaxo Group Limited | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| WO2003074469A1 (de) * | 2002-03-04 | 2003-09-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue zimtsäuresalze, verfahren zu deren herstellung und deren verwendung als arzneimittel |
| GB0208609D0 (en) * | 2002-04-13 | 2002-05-22 | Glaxo Group Ltd | Compositions |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| GB0217225D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicinal compounds |
| CA2508692C (en) | 2002-12-12 | 2012-04-03 | Altana Pharma Ag | Combination medicament |
| GB0303396D0 (en) | 2003-02-14 | 2003-03-19 | Glaxo Group Ltd | Medicinal compounds |
| SE527069C2 (sv) | 2003-06-19 | 2005-12-13 | Mederio Ag | Förfarande och anordning för administrering av läkemedelspulver |
| DK1658063T3 (da) | 2003-08-06 | 2014-05-12 | Galephar M F | Fordelagtige kombinationer til inhalering af nacystelyn og bronkodilatorer |
| WO2005087192A2 (en) * | 2004-03-12 | 2005-09-22 | Cipla Limited | Salmeterol inhalation formulations |
| MX2007000592A (es) | 2004-07-16 | 2008-03-04 | Almirall Lab | Inhalador para la administracion de farmaceuticos en polvo, y un sistema de cartuchos de polvo para uso con este inhalador. |
| BRPI0720846A2 (pt) | 2006-12-22 | 2014-03-04 | Almirall Lab | Dispositivo de inalação para fármacos na forma de pó |
| CN101744792B (zh) * | 2008-12-17 | 2013-04-17 | 张凯 | 氟替卡松丙酸酯和沙美特罗昔萘酸酯复方干粉吸入剂及其制备工艺 |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| KR20170070274A (ko) | 2009-05-29 | 2017-06-21 | 펄 테라퓨틱스 인코포레이티드 | 지속형 무스카린 안타고니스트 및 지속형 ｂ₂아드레날린 수용체 아고니스트의 폐 전달용 조성물, 및 연관된 방법 및 시스템 |
| JP6454323B2 (ja) | 2013-03-15 | 2019-01-16 | パール セラピューティクス，インコーポレイテッド | 粒子状結晶性材料のコンディショニングのための方法及びシステム |
| KR20160003183A (ko) * | 2013-04-29 | 2016-01-08 | 사노피 에스에이 | 흡입식 약학적 조성물 및 그를 포함하는 흡입기 장치 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2107715B (en) * | 1981-10-19 | 1985-11-13 | Glaxo Group Ltd | Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it |
| ZW6584A1 (en) * | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
| FR2588474B1 (fr) * | 1985-10-16 | 1987-11-27 | Cird | Compositions synergetiques anti-inflammatoires a base d'un corticosteroide et d'un beta agoniste |
-
1990
- 1990-09-05 IL IL9559090A patent/IL95590A/en not_active IP Right Cessation
- 1990-09-07 DK DK90309846.5T patent/DK0416951T3/da active
- 1990-09-07 DE DE1990605951 patent/DE19975040I2/de active Active
- 1990-09-07 NZ NZ235221A patent/NZ235221A/en unknown
- 1990-09-07 DE DE69005951T patent/DE69005951T2/de not_active Expired - Lifetime
- 1990-09-07 ES ES90309846T patent/ES2062392T3/es not_active Expired - Lifetime
- 1990-09-07 EP EP90309846A patent/EP0416951B1/en not_active Expired - Lifetime
- 1990-09-07 BE BE9000862A patent/BE1003053A3/fr not_active IP Right Cessation
- 1990-09-07 AT AT90309846T patent/ATE99941T1/de active
- 1990-09-07 IE IE325690A patent/IE65535B1/en not_active IP Right Cessation
- 1990-09-07 JP JP2235997A patent/JP3042867B2/ja not_active Expired - Lifetime
- 1990-09-07 PH PH41153A patent/PH27594A/en unknown
- 1990-09-07 CA CA002024916A patent/CA2024916C/en not_active Expired - Lifetime
- 1990-09-07 IT IT48260A patent/IT1241996B/it active Protection Beyond IP Right Term
- 1990-09-07 FR FR909011142A patent/FR2651677B1/fr not_active Expired - Lifetime
- 1990-09-07 CH CH2906/90A patent/CH680983C9/de not_active IP Right Cessation
-
1994
- 1994-11-18 SG SG166294A patent/SG166294G/en unknown
-
1995
- 1995-02-09 HK HK18695A patent/HK18695A/xx not_active IP Right Cessation
- 1995-06-02 HU HU95P/P00150P patent/HU211272A9/hu unknown
-
1999
- 1999-04-14 NL NL990012C patent/NL990012I2/nl unknown
- 1999-04-26 LU LU90392C patent/LU90392I2/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL990012I2 (nl) | 1999-09-01 |
| CA2024916A1 (en) | 1991-03-09 |
| BE1003053A3 (fr) | 1991-11-05 |
| NZ235221A (en) | 1992-11-25 |
| FR2651677A1 (fr) | 1991-03-15 |
| CA2024916C (en) | 2002-07-09 |
| JPH03167120A (ja) | 1991-07-19 |
| IE903256A1 (en) | 1991-03-13 |
| DE19975040I2 (de) | 2006-07-13 |
| DK0416951T3 (da) | 1994-02-14 |
| IL95590A0 (en) | 1991-09-16 |
| CH680983C1 (cg-RX-API-DMAC7.html) | 2008-06-25 |
| DE69005951D1 (de) | 1994-02-24 |
| HK18695A (en) | 1995-02-17 |
| ATE99941T1 (de) | 1994-01-15 |
| EP0416951A1 (en) | 1991-03-13 |
| EP0416951B1 (en) | 1994-01-12 |
| IL95590A (en) | 1996-06-18 |
| ES2062392T3 (es) | 1994-12-16 |
| IT9048260A1 (it) | 1992-03-07 |
| IT9048260A0 (it) | 1990-09-07 |
| HU211272A9 (en) | 1995-11-28 |
| LU90392I2 (fr) | 1999-06-28 |
| NL990012I1 (nl) | 1999-07-01 |
| DE69005951T2 (de) | 1994-05-26 |
| FR2651677B1 (fr) | 1993-08-06 |
| JP3042867B2 (ja) | 2000-05-22 |
| IT1241996B (it) | 1994-02-02 |
| IE65535B1 (en) | 1995-11-01 |
| CH680983C9 (cg-RX-API-DMAC7.html) | 2008-08-15 |
| SG166294G (en) | 1995-06-16 |
| CH680983A5 (cg-RX-API-DMAC7.html) | 1992-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH27594A (en) | Medicaments for the treatment of asthma and other respiratory disorders | |
| AU644094B2 (en) | Medicaments | |
| CA2123909A1 (en) | New combination of formoterol and budesonide | |
| GEP20002253B (en) | Pharmaceutical Aerosol Formulation, Proportioning Inhalator and Method for Treatment of Respiratory Diseases | |
| GB9425160D0 (en) | Medicaments | |
| CA2125666A1 (en) | Medicaments | |
| CA2093806A1 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
| GR3032374T3 (en) | Pharmaceutical compositions for systemic administration of erythropoietin via the respiratory system. | |
| EE03221B1 (et) | Inhaleeritavad ravimpreparaadid, nende valmistamise protsess ja inhalaator nende kasutamiseks | |
| CA2195065A1 (en) | Inhalation composition | |
| TW329387B (en) | Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate | |
| GB9806462D0 (en) | Improved compositions for inhalation | |
| HUP0002533A2 (hu) | Asztmaellenes gyógyszerhatóanyagok új kombinációja | |
| MY111155A (en) | Medicaments |